Search results
Ipsen drug for rare liver disease approved by FDA
BioPharma Dive via Yahoo Finance· 5 days agoThe medicine will join Intercept’s Ocaliva as a treatment option for primary biliary cholangitis. Another drug, from the now Gilead-owned CymaBay, could...
Warp Speed, Flight Attendants And Tsunamis
Jalopnik via Yahoo News· 1 day agoThere have been some awesome inventions in the world of science fiction over the years. Whether it’s the Tardis from “Dr Who” and its miraculous...
Fox News buried Paul Ryan denouncing Donald Trump as “unfit for office”
Media Matters· 3 days agoWritten by Matt Gertz Research contributions from Rob Savillo Published 06/13/24 11:47 AM EDT
Radioactive drugs strike cancer with precision
Knowable Magazine via Yahoo News· 4 days agoAt one clinic in Bad Berka, Germany, over a thousand patients were treated within a decade, showing extended survival rates compared with what’s typical...
FDA grants Shattuck Labs orphan drug status for AML treatment By Investing.com
Investing.com· 6 days agoShattuck Labs, Inc. (NASDAQ:STTK), a biotechnology firm engaged in the development of fusion...
A super sweet tale of survival in the garden after a hail storm
Denver Post· 6 days agoBut I don’t mind being sentimental about gardening, something that brings me such joy. Cooking is...
Check out some of the best conceptual stories heard on Hip Hop albums
Revolt via Yahoo News· 5 days agoHip Hop concept albums that tell a story represent a unique and immersive way for artists to convey...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 4 days agoPfizer also recently said its new drug, Adcetris, improved overall survival, progression-free ...
On the brink of an 18th title
Casper Star-Tribune· 2 days agoThere will be a record-setting 18th championship for the Boston Celtics to celebrate soon, maybe very soon. The Celtics, to their credit, are taking...
US FDA grants accelerated approval to Genfit and Ipsen's liver disease drug
AOL· 6 days ago(Reuters) -The U.S. Food and Drug Administration granted accelerated approval to French drugmakers Ipsen and Genfit's drug for a chronic inflammatory liver disease, Iqirvo ...
